Skip to main content
Join the Patient Engagement Forum.Share your experiences by joining our Patient Engagement Forum.

PGT-M conditions

The page below lists all PGT-M conditions currently authorised and awaiting consideration by the HFEA.

When publishing genetic conditions on the authorised list, we aim to be as consistent as possible with the OMIM database. However, many conditions may have several different names and we would recommend searching the list using the OMIM number for the condition as this is less likely to change throughout time.

If a condition does not appear on the list, it does not necessarily mean the condition has specifically not been authorised, it may mean that we have never before received an application from a UK centre to perform PGT-M for this condition and it has therefore never been considered by the HFEA.

Please note that we are always processing new applications to add genetic conditions to the list from UK centres licensed to perform PGT-M. This may mean that some authorised conditions may not be displayed. If you are unsure if a condition has been authorised or not, or would like any further information please contact the PGTM team at pgtm@hfea.gov.uk.

Click here for a downloadable list: approved condition list. Please note that the website page below is updated more regularly and is therefore more accurate than the downloadable list.

Condition name Status OMIM number Documents
Hemolytic Uremic Syndrome, Atypical, Susceptibility To, 3 (AHUS3) approved 612923
Hemolytic Uremic Syndrome, Atypical, Susceptibility To, 4 (AHUS4) approved 612924
Hemolytic Uremic Syndrome, Atypical, Susceptibility To, 5 (AHUS5) approved 612925
Hemolytic Uremic Syndrome, Atypical, Susceptibility To, 6 (AHUS6) approved 612926
Hemolytic Uremic Syndrome, Atypical, Susceptibility To, 7 (AHUS7) approved 615008
Hemophagocytic Lymphohistiocytosis, Familial, 2 (FHL2) approved 603553
Hemophagocytic Lymphohistiocytosis, Familial, 3 (FHL3) approved 608898
Hemophagocytic Lymphohistiocytosis, Familial, 4 (FHL4) approved 603552
Hemophagocytic Lymphohistiocytosis, Familial, 5 (FHL5) approved 613101
Hennekam Lymphangiectasia-Lymphedema Syndrome 1; HKLLS1 approved 235510
Hennekam Lymphangiectasia-Lymphedema Syndrome 2; HKLLS2 approved 616006
Hennekam Lymphangiectasia-Lymphedema Syndrome 3; HKLLS3 approved 618154
Hereditary Angioedema (HAE) Type I & Type II approved 106100
Hereditary Angioedema (HAE) Type III approved 610618
Hereditary diffuse gastric cancer (HDGC) approved 137215
Hereditary Emberger Syndrome approved 614038
Hereditary Haemorrhagic Telangiectasia (HTT) or Rendu-Osler-Weber Syndrome approved 187300
Hereditary Haemorrhagic Telangiectasia Type 2 (HHT2) approved 600376
Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC) approved 150800
Hereditary motor and sensory neuropathy, type IIc (HMSN2C) approved 606071